Ultragenyx Pharmaceutical

Ultragenyx is a biopharmaceutical company focused on developing novel therapies for rare and ultra-rare genetic diseases. The company's portfolio includes approved treatments for metabolic disorders and a robust pipeline targeting genetic diseases with high unmet medical need. Ultragenyx employs innovative approaches including gene therapy and substrate reduction.